Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH

Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH

Feb 03, 2022 by Business Wire Health: Oncology News

Key Facts

  • Dr. Reddy's will acquire Nimbus Health for an upfront payment plus performance and milestone-based earn-outs over the next four years Founded in 2018, Nimbus Health is one of the pioneer companies for medical cannabis in Germany.
  • The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients.
  • The company will be operating under the brand Nimbus Health and as a wholly-owned subsidiary of Dr. Reddy's.
  • We are very excited that with Nimbus joining Dr. Reddy's family, together with Linus and Alessandro, we embark on a new, exciting journey of medical cannabis, which supports Dr. Reddy's mission of meeting unmet patient needs."

Click To Read Full Article

GROUP
PERSON
ORGANIZATION
PERCENT
GEOGRAPHY
MONEY
LOCATION
MISCELLANEOUS

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?